Asante Announces Correction to Press Release
April 24, 2024 21:18 ET
|
Asante Gold Corporation
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Asante Gold Corporation (“Asante” or the “Company” CSE:ASE | GSE:ASG | FRANKFURT:1A9 | U.S.OTC:ASGOF) announces a correction to the...
Clear Blue Technologies Announces Extension of Warrant Expiry
April 24, 2024 17:01 ET
|
Clear Blue Technologies International Inc.
TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Clear Blue Technologies International Inc. (TSXV: CBLU) (FRANKFURT: OYA) (OTCQB: CBUTF) is pleased to announce it has extended the expiry date of an...
ChampionX Reports First Quarter 2024 Results
April 24, 2024 17:00 ET
|
ChampionX Corporation
Revenue of $922.1 million, decreased 3% year-over-yearNet income attributable to ChampionX of $112.9 million, increased 78% year-over-yearAdjusted net income of $96.4 million, increased 17%...
Hapbee Announces Closing of Private Placement
April 24, 2024 16:33 ET
|
Hapbee Technologies, Inc.
VANCOUVER, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company...
Surge Copper Announces Closing of Private Placement for $1.0 million
April 24, 2024 16:30 ET
|
Surge Copper Corp.
Vancouver, British Columbia, April 24, 2024 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) announces that it has closed its...
Entourage Health to Report Fiscal Year 2023 Financial Results
April 24, 2024 16:16 ET
|
Entourage Health Corp.
TORONTO, April 24, 2024 (GLOBE NEWSWIRE) -- Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) ("Entourage" or the "Company"), a Canadian producer and distributor of award-winning...
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistance
April 24, 2024 16:05 ET
|
QIAGEN N.V.
Venlo, the Netherlands, April 24, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the QIAseq xHYB Mycobacterium tuberculosis Panel for...
QIAGEN erweitert Tuberkulose-Portfolio: Neues NGS-Panel unterstützt Echtzeit-Überwachung und Bekämpfung antimikrobieller Resistenzen
April 24, 2024 16:05 ET
|
QIAGEN N.V.
VENLO, Niederlande, April 24, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute die Einführung des QIAseq xHYB Mycobacterium tuberculosis Panel zu...
Basilea-Aktionäre genehmigen an der Generalversammlung alle Anträge des Verwaltungsrats
April 24, 2024 12:00 ET
|
Basilea Pharmaceutica AG
Allschwil, 24. April 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und dem Ziel, Patienten zu helfen, die an schweren...
Basilea shareholders approve all proposals of the board of directors at the annual general meeting
April 24, 2024 12:00 ET
|
Basilea Pharmaceutica AG
Allschwil, Switzerland, April 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial...